134 related articles for article (PubMed ID: 35532255)
1. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and LC-MS approachs to explore the active compounds and mechanisms of Yuanjiang decoction for treating bradyarrhythmia.
Wang X; Zhang X; Li J; Fu J; Zhao M; Zhang W; Weng W; Li Q
Comput Biol Med; 2023 Jan; 152():106435. PubMed ID: 36535207
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of
Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
[No Abstract] [Full Text] [Related]
4. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
5. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
6. [
Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
[TBL] [Abstract][Full Text] [Related]
7. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
8. Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.
Li X; Ma J; Guo L; Dong C; Zhu G; Hong W; Chen C; Wang H; Wu X
Oxid Med Cell Longev; 2022; 2022():3145938. PubMed ID: 35528524
[TBL] [Abstract][Full Text] [Related]
9. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome.
Wu Z; Yang T; Ma H
Medicine (Baltimore); 2023 Apr; 102(15):e33212. PubMed ID: 37058016
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
Shi N; Zhou Y; Ma H
Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
[TBL] [Abstract][Full Text] [Related]
12. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome.
Cai YL; Zhang F; Dou XX; Zeng HW; Wu GS; Liang YL; Xu XK; Zhao J; Ye J; Zhang WD
J Ethnopharmacol; 2022 Sep; 295():115442. PubMed ID: 35688255
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Mechanism of Zhibaidihuang Decoction against IgA Nephropathy Using Network Pharmacology and Molecular Docking Analyses.
Deng X; Luo Y; Lu M; Guan T; Li Y; Guo X
Tohoku J Exp Med; 2022 Dec; 259(1):37-47. PubMed ID: 36288951
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology reveals the potential mechanism of Baiying Qinghou decoction in treating laryngeal squamous cell carcinoma.
Gao K; Zhu Y; Wang H; Gong X; Yue Z; Lv A; Zhou X
Aging (Albany NY); 2021 Dec; 13(24):26003-26021. PubMed ID: 34986125
[TBL] [Abstract][Full Text] [Related]
16. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
19. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
20. Exploring the molecular targets and mechanism of
Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
